High-Quality Nebivolol Hydrochloride 152520-56-4: Premium API for Cardiovascular Drugs
ProcurenetShort description
High Quality Nebivolol Hydrochloride 152520-56-4 – Active Pharmaceutical Ingredient (API) for Cardiovascular Medicines
- Nebivolol Hydrochloride 152520-56-4 is a pharmaceutical-grade API of superb quality.
- It is used mainly in creating medications for cardiovascular ailments, operating as a selective beta-1 adrenergic blocking agent.
- This compound not only lowers blood pressure but also shows vasodilating qualities that assist in relaxing and expanding blood vessels.
- Strict quality control protocols in production are followed as per Good Manufacturing Practices (GMP) guidelines to meet regulatory necessities and safety standards.
- With a considerable monthly production capacity, this product is designed to satisfy global demand.
-
Procurenet Team Tshim Sha Tsui
Hong Kong
3 years
Description
High-Quality Nebivolol Hydrochloride 152520-56-4: The Premium API for Cardiovascular Medicines
Rigorous in efficacy and quality, Nebivolol Hydrochloride is a reputable active pharmaceutical ingredient (API). Its therapeutic utility in formulating potent cardiovascular medications is unparalleled, marking its irreplaceable role in pharmaceutical applications.
Key features
- CAS Number: 152520-56-4, for an unequivocal identification and accuracy in chemical research processes.
- Molecular Formula: C22H26ClF2NO4, highlighting the precise configuration that is integral to its therapeutic application.
- Molecular Weight: 441.9 g/mol, reflecting its high degree of purity.
- Compound Name: Nebivolol Hydrochloride - it offers a unique chemical identity delivering precise and effective results.
- IUPAC name: 2-Propanol, α,α'-[iminobis[(methylene)oxy-κO]]bis[6-fluoro-3,4-dihydro-1H-1,3]dioxolo[4,5-b][4,5-d]pyridin-1-yl]-, hydrochloride (1:1), (±)-
- Solubility: Water-soluble, due to meticulous manufacturing practices.
- Density: Approximately 1.3g/cm3; a balance that ensures optimal formulation.
- Mechanism of Action: A Beta1 receptor blocker with nitric oxide enhancing vasodilatory effects used in the treatment of hypertension.
- Pharmacological Classification:A Cardiovascular Drug.
- ADME:Entirely absorbed post oral administration, metabolized via direct glucuronidation, and primarily eliminated via urinary excretion.
- Carcinogenicity and Teratogenicity: Neither carcinogenic nor teratogenic. Please follow safety instructions provided in data sheets and local regulations.
- Therapeutic Uses:Primarily used for the treatment of hypertension and heart failure.
- Dosage:Administer under professional supervision as individual responses may vary.
- Contraindications:Not recommended for individuals hypersensitive to Nebivolol Hydrochloride or similar compounds.
In both quality and reliability, Nebivolol Hydrochloride stands as an outstanding representation of our range of APIs. Spirited by its success, we strive to maintain high production capacity and ensure worldwide availability.
